Your browser doesn't support javascript.
loading
Genomic origin and EGFR-TKI treatments of pulmonary adenosquamous carcinoma.
Lin, G; Li, C; Li, P S; Fang, W Z; Xu, H P; Gong, Y H; Zhu, Z F; Hu, Y; Liang, W H; Chu, Q; Zhong, W Z; Wu, L; Wang, H J; Wang, Z J; Li, Z M; Lin, J; Guan, Y F; Xia, X F; Yi, X; Miao, Q; Wu, B; Jiang, K; Zheng, X B; Zhu, W F; Zheng, X L; Huang, P S; Xiao, W J; Hu, D; Zhang, L F; Fan, X R; Mok, T S K; Huang, C.
Afiliação
  • Lin G; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Li C; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China; Department of Pathology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China; Fujian Provincial Key Laboratory of Translational Cancer Medicine, Fuzhou, China.
  • Li PS; Geneplus-Beijing, Beijing, China.
  • Fang WZ; Department of Oncology, 900 Hospital of the Joint Logistics Team, Clinical Medical College of Fujian Medical University in 900 Hospital of the Joint Logistics Team, Fuzhou, China.
  • Xu HP; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Gong YH; Geneplus-Beijing, Beijing, China.
  • Zhu ZF; Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Fudan University Shanghai Medical School, Shanghai, China.
  • Hu Y; Department of Medical Oncology, Chinese PLA General Hospital/Medical School of Chinese PLA, Beijing, China.
  • Liang WH; Department of Thoracic Oncology, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Institute of Respiratory Disease & China State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou, China.
  • Chu Q; Department of Oncology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Zhong WZ; Guangdong Lung Cancer Institute, Guangdong General Hospital & Guangdong Academy of Medical Sciences, Guangzhou, China.
  • Wu L; Department of Thoracic Medical Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China.
  • Wang HJ; Henan Cancer Hospital/Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China.
  • Wang ZJ; State Key Laboratory of Molecular Oncology, Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Li ZM; Shanghai Lung Cancer Center, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China.
  • Lin J; Department of Medical Oncology, The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Guan YF; Geneplus-Beijing, Beijing, China.
  • Xia XF; Geneplus-Beijing, Beijing, China.
  • Yi X; Geneplus-Beijing, Beijing, China.
  • Miao Q; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Wu B; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Jiang K; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Zheng XB; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Zhu WF; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Zheng XL; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Huang PS; Department of Pathology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Xiao WJ; Department of Pathology, School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Hu D; Department of Pathology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Zhang LF; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Fan XR; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
  • Mok TSK; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, China. Electronic address: tony@clo.cuhk.edu.hk.
  • Huang C; Department of Thoracic Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou, China.
Ann Oncol ; 31(4): 517-524, 2020 04.
Article em En | MEDLINE | ID: mdl-32151507
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Adenoescamoso / Neoplasias Pulmonares Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Adenoescamoso / Neoplasias Pulmonares Tipo de estudo: Observational_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China